πŸ‡ΊπŸ‡Έ FDA

Intelligence Platform

Patents

Browse 55 pharma-relevant US patents (A61K/A61P) linked to tracked companies. Patent cliff and LOE intelligence for BD teams.

29,054 patents indexed
patent

US 10961535

Compositions and agents against hepatitis B virus and uses thereof

ARCTURUS THERAPEUTICS, INC. Β· Granted Tue Mar 30 2021 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Mar 25 2041 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 10815463

Messenger UNA molecules and uses thereof

ARCTURUS THERAPEUTICS, INC. Β· Granted Tue Oct 27 2020 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Oct 22 2040 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 10781169

Method of synthesis of an ionizable cationic lipid

ARCTURUS THERAPEUTICS, INC. Β· Granted Tue Sep 22 2020 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Sep 17 2040 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 10731154

Acyl-amino-LNA and/or hydrocarbyl-amino-LNA oligonucleotides

ARCTURUS THERAPEUTICS, INC. Β· Granted Tue Aug 04 2020 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Jul 30 2040 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 10683500

UNA oligomers having reduced off-target effects in gene silencing

ARCTURUS THERAPEUTICS, INC. Β· Granted Tue Jun 16 2020 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Jun 11 2040 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 10604758

Therapeutic oligomers for treating amyloidosis

ARCTURUS THERAPEUTICS, INC. Β· Granted Tue Mar 31 2020 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Mar 26 2040 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 10556861

Ionizable cationic lipid for RNA delivery

ARCTURUS THERAPEUTICS, INC. Β· Granted Tue Feb 11 2020 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Feb 06 2040 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 10519447

Therapeutic UNA oligomers and uses thereof

ARCTURUS THERAPEUTICS, INC. Β· Granted Tue Dec 31 2019 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Dec 26 2039 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 10487105

Trinucleotide MRNA cap analogs

ARCTURUS THERAPEUTICS, INC. Β· Granted Tue Nov 26 2019 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Nov 21 2039 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 10457945

UNA oligomers for therapeutics with prolonged stability

ARCTURUS THERAPEUTICS, INC. Β· Granted Tue Oct 29 2019 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Oct 24 2039 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 10421964

UNA oligomers and compositions for treating amyloidosis

ARCTURUS THERAPEUTICS, INC. Β· Granted Tue Sep 24 2019 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Sep 19 2039 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 10399937

Ionizable cationic lipid for RNA delivery

ARCTURUS THERAPEUTICS, INC. Β· Granted Tue Sep 03 2019 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Aug 29 2039 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 10383952

Ionizable cationic lipid for RNA delivery

ARCTURUS THERAPEUTICS, INC. Β· Granted Tue Aug 20 2019 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Aug 15 2039 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 10369232

Allele selective gene editing and uses thereof

ARCTURUS THERAPEUTICS, INC. Β· Granted Tue Aug 06 2019 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Aug 01 2039 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 10227302

Ionizable cationic lipid for RNA delivery

ARCTURUS THERAPEUTICS, INC. Β· Granted Tue Mar 12 2019 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Mar 07 2039 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 9982259

Transthyretin allele selective UNA oligomers for gene silencing

ARCTURUS THERAPEUTICS, INC. Β· Granted Tue May 29 2018 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon May 24 2038 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 9962449

MultiLigand agent for drug delivery

ARCTURUS THERAPEUTICS, INC. Β· Granted Tue May 08 2018 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon May 03 2038 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 9951002

Ionizable cationic lipid for RNA delivery

ARCTURUS THERAPEUTICS, INC. Β· Granted Tue Apr 24 2018 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Apr 19 2038 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 9944929

UNA single stranded oligomers for therapeutics

ARCTURUS THERAPEUTICS, INC. Β· Granted Tue Apr 17 2018 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Apr 12 2038 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 9896413

Ionizable cationic lipid for RNA delivery

ARCTURUS THERAPEUTICS, INC. Β· Granted Tue Feb 20 2018 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Feb 15 2038 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 9856475

Formulations for treating amyloidosis

ARCTURUS THERAPEUTICS, INC. Β· Granted Tue Jan 02 2018 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Dec 28 2037 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 9850202

Ionizable cationic lipid for RNA delivery

ARCTURUS THERAPEUTICS, INC. Β· Granted Tue Dec 26 2017 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Dec 21 2037 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 9670152

Ionizable cationic lipid for RNA delivery

ARCTURUS THERAPEUTICS, INC. Β· Granted Tue Jun 06 2017 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Jun 01 2037 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 9593077

Ionizable cationic lipid for RNA delivery

ARCTURUS THERAPEUTICS, INC. Β· Granted Tue Mar 14 2017 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Mar 09 2037 00:00:00 GMT+0000 (Coordinated Universal Time)

granted